The Clinical Risk Liaison serves as the primary connection between the Transition and Clinical Teams and the Quality and Patient Safety Department. Reporting to the Director of Risk Management and Patient Safety, this role is charged with proactively identifying, prioritizing, and mitigating safety risks throughout the hospital transformation effort. This …
This position will start in October 2026. The Patient Representative (PR) is the “first impression” a patient has of Dana-Farber Cancer Institute (DFCI). As the first point of contact, this role is critical to a patient’s experience and their entry into the DFCI system. PRs provide call center and administrative …
Reporting to the Manager of Prior Authorization, the Prior Authorization Supervisor is responsible for managing the operational workflows and staff obtaining drug and laboratory procedure prior authorizations from third-party payers. This work will primarily address on-/off-label drugs and molecular pathology procedures provided in the outpatient hospital setting. A key focus …
The Regulatory Coordinator II (RC II) will work under the direction of the Director of Clinical Research Administration for the Clinical Trials Office to complete the regulatory requirements of the clinical research projects. The RC coordinates aspects of protocol submissions, prepares and submits regulatory documents, and maintains records on assigned …
Under the direction of the Director of Patient Safety & Risk Management, the Risk Manager is a member of the Patient Safety & Risk Management team of the Dana-Farber Cancer Institute’s (DFCI) Quality and Patient Safety (QPS) Department is responsible for identification, evaluation, and mitigation of risk at DFCI, including …
Must have a working knowledgeable of basic and complex principles and practices of cell processing and experience as an auditor and compliance specialist. The QA/QI Specialist is responsible assisting in the monitoring for quality to ensure that systems are appropriate, current and being adhered to by all staff of the …
Read more about ""The Regulatory Coordinator II (RC II) will work under the direction of the Director of Clinical Research Administration for the Clinical Trials Office to complete the regulatory requirements of the clinical research projects. The RC coordinates aspects of protocol submissions, prepares and submits regulatory documents, and maintains records on assigned …
Read more about ""This position will start in October 2026. The Patient Representative (PR) is the “first impression” a patient has of Dana-Farber Cancer Institute (DFCI). As the first point of contact, this role is critical to a patient’s experience and their entry into the DFCI system. PRs provide call center and administrative …
Read more about ""